CClinicalTrials.gg
Status unknownNCT02436070Updated Nov 22, 2017

Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma

An interventional study of Targeted text messages and General text messages in Asthma, sponsored by Children's Hospitals and Clinics of Minnesota. Status unknown at 2 sites in United States. Open to participants aged 4 Years to 17 Years. Per ClinicalTrials.gov, last updated 2017-11-22.

Sponsored by Children's Hospitals and Clinics of Minnesota · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Nov 2017), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
195
Allocation
Randomized
Ages
4 Years to 17 Years
Sex
All
01

Study summary

BACKGROUND Asthma is a prevalent and troublesome pediatric condition. In 2013, Emergency Department (ED) providers treated over 3,500 cases of asthma-related complaints at Children's Hospitals and Clinics of Minnesota. Pediatric ED visits for asthma exceeds billions of dollars annually when including direct cost and lost productivity. Many of these visits and resultant costs are avoidable. Patients with well-controlled asthma do not typically exhibit these patterns, while patients with poorly controlled asthma show patterns of increased utilization of healthcare resources and lower quality of life. Evidence suggests that a text message reminder and educational program might positively influence pediatric asthma care practices.

RESEARCH QUESTION Does a targeted ED based text message intervention program improve outpatient follow-up and routine preventive care in pediatric asthma patients?

METHODS Study subjects will be block randomized based on age and insurance group. The experimental group will receive text messages with guidance towards follow-up care with their PCP and the importance of the flu vaccine for children with asthma. The control group will receive a series of educational self-care and health based text messages unrelated to asthma or the flu vaccine. Some self-report of behaviors will be captured via text message response.

ANALYSIS Primary outcomes for the educational versus targeted text message groups will be compared use Chi-square tests. Additional adjustments may be applied for missing data or if, despite randomization, there is substantial imbalance between group in key covariates (eg race/ethnicity, insurance type or asthma severity.)

02

Conditions studied

  • Asthma

Browse trials for

Keywords

  • Pediatrics
  • Emergency Medicine
  • Text messaging
03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's planned enrollment of 195 is above the median of 83 across 2,752 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

Children's Hospitals and Clinics of Minnesota is the lead sponsor of 49 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Caregivers of patients aged 4 - 17 years (inclusive) will be eligible for study participation if they meet the following criteria:

    1. Presentation to the ED with a chief complaint related to an asthma exacerbation such as shortness of breath, respiratory distress, wheezing, etc...
    2. Receive an albuterol treatment in the ED
    3. Previous history of asthma as represented in the medical record or by parental report
    4. Have a cell phone that is able to receive text messages
    5. Able to communicate and provide consent in English or Spanish

Exclusion criteria

Exclusion Criteria:

  • Caregivers of patients will be excluded from this study for the following reasons:

    1. First episode of wheezing
    2. Admitted to the hospital
    3. Co-morbid respiratory disease:

      1. Cystic fibrosis
      2. Bronchiectasis
      3. Pulmonary hypertension
      4. Other chronic lung disease
    4. Current cancer diagnosis
    5. Previous cardiovascular surgery
    6. Inflammatory bowel disease
    7. Sickle Cell disease
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
195 participants (estimated)

Study arms

  • Active comparator
    Control

    Subjects receive general, health-related text messages applicable for children with asthma.

    Behavioral: General text messages

  • Experimental
    Test group

    Subjects receive specific, targeted text messages for post-emergency department discharge asthma care.

    Behavioral: Targeted text messages

Interventions

  • BehavioralTargeted text messages

    Subjects received text messages specific to post ED asthma follow-up

  • BehavioralGeneral text messages

    Subjects received text messages generalized to children with asthma

06

What researchers measure

Primary outcomes

  1. Follow-up care with primary care provider

    Assessed via text and follow-up call if no response to text message

    Time frame: 1 week after emergency department discharge

Secondary outcomes

  1. Influenza vaccine

    Assessed via text and follow-up call if no response to text message

    Time frame: 30 days after emergency department discharge

  2. Return visit to the emergency department

    Assessed via text and follow-up call if no response to text message; Our health record also checked for return visits

    Time frame: 30 days after the inaugural emergency department visit

07

Study locations

2 of 2 sites recruiting
  • Children's Hospitals and Clinics of Minnesota - Emergency Department
    Minneapolis, Minnesota 55404, United States
    • Anupam B Kharbanda, MD · Contact
    Recruiting
  • Children's Minnesota
    Saint Paul, Minnesota, United States
    • Anupam Kharbanda, MD · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02436070
Lead sponsor
Children's Hospitals and Clinics of Minnesota
Collaborators
HealthPartners Institute
Responsible party
Sponsor
First posted
May 6, 2015
Start date
Oct 2014
Primary completion
Dec 2018 (estimated)
Completion
Dec 2018 (estimated)
Last update
Nov 22, 2017

Study contacts

Heidi Vander Velden
Contact
heidi.vandervelden@childrensmn.org
6128137892

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion